Impact of Pulmonary Follow-up After Stem Cell Graft

Impact of Systematic Pulmonary Follow-up After Hematopoietic Stem Cell Transplantation

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03349372

Enrollment

227

Registered

2017-11-21

Start date

2016-11-01

Completion date

2017-10-31

Last updated

2017-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematologic Neoplasms

Brief summary

Allogeneic hematopoietic stem cell transplantation is the only possible treatment for many malignant and non-malignant hemopathies. The graft-versus-host immunological reaction (GvH) is a frequent and sometimes serious complication. The objective is to study whether a systematic and early follow-up by a lung specialist of allografted patients would allow an earlier diagnosis of GvH with pulmonary complications.

Interventions

PROCEDUREHematopoietic stem cell transplantation

Hematopoietic stem cell transplantation

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* 18 years of age or older * patients with a hematopoietic stem cell transplantation

Exclusion criteria

* Death within 100 days post-surgery

Design outcomes

Primary

Measure	Time frame	Description
Medical complications	Medical complications, especially Graft-versus-Host reaction with pulmonary complications occurring within 100 days post-surgery are studied	100 days after allograft

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026